Tuesday, October 21, 2008: 8:00 AM
Columbus A-C (Hyatt Regency Penns Landing)
Poster Number Acronyms
BIAS ASSOCIATED WITH EVENT-HISTORY HETEROGENEITY IN MARKOV MODELS
Tanya G.K. Bentley, PhD, UCLA, Los Angeles, CA, Karen M. Kuntz, ScD, University of Minnesota, Minneapolis, MN and Jeanne S. Ringel, PhD, RAND Corporation, Santa Monica, CA
THE ROLE OF BISPHOSPHONATE THERAPY IN MULTIPLE MYELOMA PATIENTS: A PERSPECTIVE ON OSTEONECROSIS OF THE JAW AND QUALITY OF LIFE
Mona Akbari, Harvard University School of Public Health, Boston, MA, Rebecca Miksad, MD, Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA and Milton C. Weinstein, PhD, Harvard School of Public Health, Boston, MA
THE VALUE OF COST-EFFECTIVENESS INFORMATION FOR THE DECISION ON GENETIC SCREENING FOR HAEMOCHROMATOSIS IN GERMANY
Wolf Rogowski, PhD1, Scott D. Grosse, PhD2, Juergen John, PhD1 and Stephen Palmer, MSc3, (1)Helmholtz Zentrum München. German Research Center for Environmental Health (GmbH), Neuherberg, Germany, (2)Centers for Disease Control and Prevention, Atlanta, GA, (3)University of York, York, United Kingdom
THE PERSONAL FINANCIAL BURDEN OF CANCER IN THE U.S.: IMPLICATIONS FOR INSURANCE DESIGN
Eric A. Finkelstein, PhD1, Florence K. Tangka, PhD, MS, BS2, Justin G. Trogdon, PhD1, Susan Sabatino, MD2 and Lisa Richardson, MD3, (1)RTI International, Research Triangle Park, NC, (2)CDC, Atlanta, GA, (3)Centers for Disease Control and Prevention, Atlanta, GA
ESTIMATING NATIONAL PATIENT POPULATION SIZES FOR BUDGET IMPACT: A CENSUS-BASED EPIDEMIOLOGICAL MODEL PREDICTING THE NUMBER OF WOMEN WITH BONE METASTASES SUBSEQUENT TO BREAST CANCER IN THE UK
Aline Gauthier, MSc1, Alessandra Gennari, MD, PhD2, Monique Martin, MSc, MBA1 and Andreas Maetzel, MD, MSc, PhD3, (1)i3 Innovus, Uxbridge Middlesex, United Kingdom, (2)National Cancer Research Institute, Genoa, Italy, (3)Amgen (Europe) GmbH, Zug, Switzerland
MEASURING THE COST OF PATIENT-GENERATED ELECTRONIC MEDICAL RECORD DATA IN PEDIATRIC INFLAMATORY BOWEL DISEASE PATIENTS
Duane Steward, DVM, MSIE, PhD, Gabriela Ramirez-Garnica, PhD, MPH, David Milov, MD and Ian Nathanson, MD, Nemours, Orlando, FL
TO PREVENT OR TREAT: THE COST-EFFECTIVENESS OF EXPANDED HIV SCREENING OR ANTIRETROVIRAL THERAPY
Elisa F. Long, PhD, Yale University, New Haven, CT CA, USA USA, Douglas K. Owens, MD, MS, VA Palo Alto Health Care System & Stanford University, Palo Alto, CA and Margaret L. Brandeau, PhD, Stanford University, Stanford, CA
COST-EFFECTIVENESS OF EXPANDED TESTING FOR HIV IN HIGHLY ENDEMIC REGIONS
Eran Bendavid, MD, Stanford University, Stanford, CA, Gillian D. Sanders, PhD, Duke, Durham, NC and Douglas K. Owens, MD, MS, VA Palo Alto Health Care System & Stanford University, Palo Alto, CA
COST-EFFECTIVENESS OF PROGRAMMATIC MODELS FOR PROVISION OF ANTIRETROVIRAL THERAPY IN RESOURCE-LIMITED SETTINGS
Joseph B. Babigumira, MBChB, MS1, Ajay K. Sethi, PhD, MHS2, Kathleen A. Smyth, PhD2 and Mendel E. Singer, PhD2, (1)University of Washington, Seattle, WA, (2)Case Western Reserve University School of Medicine, Cleveland, OH
ANTIRETROVIRAL STRATEGIES AND TREATMENT MONITORING IN RESOURCE-LIMITED SETTINGS – A COST-EFFECTIVENESS ANALYSIS
Eran Bendavid, MD1, Robin Wood, FCP, MMed, DTM&H2, David A. Katzenstein, MD1, Ahmed M. Bayoumi, MD, MSc3 and Douglas K. Owens, MD, MS4, (1)Stanford University, Stanford, CA, (2)University of Cape Town, Cape Town, South Africa, (3)Centre for Research on Inner City Health, the Keenan Research Centre in the Li Ka Shing Knowledge Institute, Toronto, ON ON ON, Canada Canada Canada, (4)VA Palo Alto Health Care System & Stanford University, Palo Alto, CA
COST AND EFFECTIVENESS IMPLICATIONS OF DIAGNOSING HIV INFECTION IN HOSPITALS: A COMPARISON OF ROUTINE SCREENING IN EMERGENCY DEPARTMENTS AND DIAGNOSTIC TESTING IN INPATIENT UNITS
Vimalanand S. Prabhu, PhD, MMgmt, BE1, Angela B. Hutchinson, PhD, MPH2, Stephanie Sansom, PhD2, Sada Soorapanth, PhD3 and Paul Farnham, PhD4, (1)Centers for Disease Control and Prevention, Decatur, GA, (2)Centers for Disease Control and Prevention, Atlanta, GA, (3)San Francisco State University, San Francisco, CA, (4)Georgia State University, Atlanta, GA
HIV PRE-EXPOSURE PROPHYLAXIS (PREP) IN THE UNITED STATES: LIFETIME INFECTION RISK, CLINICAL OUTCOMES, AND COST-EFFECTIVENESS
A. David Paltiel, PhD1, Kenneth A. Freedberg, MD, MSc2, Callie A. Scott, BA2, Bruce R. Schackman, PhD3, Elena Losina, PhD4, Bingxia Wang, PhD2, George R. Seage, DSc5, Caroline E. Sloan, AB2, Paul E. Sax, MD6 and Rochelle P. Walensky, MD, MPH2, (1)Yale School of Medicine, New Haven, CT, (2)Massachusetts General Hospital, Boston, MA, (3)Weill Cornell Medical College, New York, NY, (4)Brigham and Womens Hospital / Harvard Medical School, Boston, MA, (5)Harvard School of Public Health, Boston, MA, (6)Brigham and Women's Hospital, Boston, MA
TRAJECTORIES OF HEALTH-RELATED QUALITY OF LIFE (HRQL) DIFFER AMONG AGE GROUPS: RESULTS FROM AN 8-YEAR LONGITUDINAL STUDY
Keiko Asakawa, MA, MBA1, Ambikaipakan Senthilselvan, PhD2, David Feeny, PhD3, Jeffrey Johnson, PhD2 and Darryl Rolfson, MD2, (1)University of Alberta, Ottawa, ON, Canada, (2)University of Alberta, Edmonton, AB, Canada, (3)Health Utilities, Inc., and Kaiser Permanente Northwest Center for Health Research, Portland, OR
QUALITY OF LIFE FOLLOWING ANTIVIRAL THERAPY FOR CHRONIC HCV INFECTION
Ava John-Baptiste, MHSc1, George Tomlinson, PhD1, Priscilla Hsu, BS2, Mel Krajden, MD2, Jenny Heathcote, MD1, Audrey Laporte, PhD1, Eric Yoshida, MD2, Frank Anderson, MD2 and Murray D. Krahn, MD, MSc1, (1)University of Toronto, Toronto, ON, Canada, (2)University of British Columbia, Vancouver, BC, Canada
PREFERENCE AND NON-PREFERENCE BASED MEASURES OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEPATITIS B
Gloria Woo, MSc, Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada, M. Sherman, MBBCH, PHd, University Health Network, Toronto, ON, Canada, Jenny Heathcote, MD, University of Toronto, Toronto, ON, Canada and Murray D. Krahn, MD, MSc, University Health Network, and University of Toronto, Toronto, ON, Canada
THE NATIONAL HEALTH MEASUREMENT STUDY: A PUBLIC DATA SET FOR HEALTH-RELATED QUALITY-OF-LIFE RESEARCH
Dennis G. Fryback, PhD1, Nancy Cross Dunham, PhD1, Mari Palta, PhD1, Janel Hanmer, PhD1, Dasha Cherepanov, BS1, Ron D. Hays, PhD2, Robert M. Kaplan, PhD2, Theodore G. Ganiats, MD3, David Feeny, PhD4 and Paul Kind, MPhil5, (1)University of Wisconsin, Madison, WI, (2)University of California, Los Angeles, Los Angeles, CA, (3)University of California, San Diego, La Jolla, CA, (4)Health Utilities, Inc., Dundas, ONT, and Kaiser Permanente Northwest Center for Health Research, Portland, OR, (5)Centre for Health Economics, University of York, York, United Kingdom
ARE LIVING-DONOR LIVER TRANSPLANTS TIMED TO MAXIMIZE LIFE EXPECTANCY?
Burhaneddin Sandikci, MS1, Sepehr Nemati Proon, MS1, Andrew J. Schaefer, PhD1 and Mark S. Roberts, MD, MPP2, (1)University of Pittsburgh, Pittsburgh, PA, (2)University of Pittsburgh School of Medicine, Pittsburgh, PA
AUTOMATIC DECISION MAKING PROCESS FOR CLASSIFICATION OF FMRI PATTERNS INTEGRATING THE PRINCIPAL COMPONENT ANALYSIS AND THE LATERALITY INDEX IN PEDIATRIC EPILEPSY
Xiaozhen You1, Malek Adjouadi, PhD1, Magno R. Guillen1, Byron Bernal, MD2, Melvin Ayala, PhD1, Armando Barreto, PhD1, Naphtali Rishe1 and William D. Gaillard, PhD3, (1)Florida International University, Miami, FL, (2)Miami Children Hospital, Miami, FL, (3)Georgetown University Hospital, Washington, DC
INTERPROFESSIONAL APPROACHES TO SHARED DECISION MAKING IN PRIMARY CARE: CREATING AND ACHIEVING CONSENSUS ON A NEW CONCEPTUAL MODEL
France Légaré, MD, PhD1, Dawn Stacey, PhD2, François-Pierre Gauvin, PhD(c)3, Glyn Elwyn, MD, PhD4, Pierre Pluye, PhD5, Marie-Pierre Gagnon, PhD6, Dominick L. Frosch, PhD7, Margaret B. Harrison, PhD8, Jennifer Kryworuchko, PhD (c)9, Sandra Dunn, PhD (c)9, Sophie Pouliot10, Sophie Desroches, RD, PhD1 and Ian Graham, PhD2, (1)CHUQ Research Center-Hôpital St-François d'Assise, Quebec, QC, Canada, (2)Ottawa Health Research Institute, Ottawa, ON, Canada, (3)McMaster University, Hamilton, ON, Canada, (4)University of Wales Cardiff, Cardiff, United Kingdom, (5)McGill University, Montreal, QC, Canada, (6)University Laval and CHUQ Research center, Québec, QC, Canada, (7)UCLA, Los Angeles, CA, (8)Queen's University, Kingston, ON, Canada, (9)Ottawa University, Ottawa, ON, Canada, (10)Laval University, Quebec, QC, Canada
ECONOMIC AND OTHER BARRIERS TO ADOPTING BETTER NUTRITION AND PHYSICAL ACTIVITY BEHAVIORS AMONG OVERWEIGHT CHILDREN
Kendrin Sonneville, MS, RD, LDN1, Nancy Lapelle, PhD2, Elsie Taveras, MD, MPH3, Matthew Gillman, MD, SM3 and Lisa Prosser, PhD4, (1)Harvard School of Public Health, Boston, MA, Boston, MA, (2)University of Massachusetts Medical School, Worcester, MA, (3)Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, (4)University of Michigan, Ann Arbor, MI
ADAPTIVE CONJOINT ANALYSIS AS INDIVIDUAL PREFERENCE ASSESSMENT TOOL: FEASIBILITY THROUGH THE INTERNET AND RELIABILITY OF PREFERENCES
Arwen H. Pieterse, PhD1, Frank Berkers, PhD2, Monique C.M. Baas-Thijssen1, Corrie A.M. Marijnen, PhD3 and Anne M. Stiggelbout, PhD1, (1)Leiden University Medical Center, Leiden, Netherlands, (2)SKIM Software, Rotterdam, Netherlands, (3)Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands
THE EFFECT OF UNCERTAINTY ON PATIENTS PREFERRED ROLE IN DECISION MAKING
Liana Fraenkel, MD, MPH, Yale University, New Haven, CT, Ellen Peters, Ph.D., Decision Research, Eugene, OR and Paul R. Falzer, PhD, Yale School of Medicine, West Haven, CT
PREFERENCES FOR COLORECTAL CANCER SCREENING AND UTLIZATION IN A LARGE MULTI-SPECIALTY PRACTICE
Sarah T. Hawley, PhD, MPH1, Amy McQueen, PhD2, Tony Greisinger, PhD3, Judy Bettencourt, MPH4, Leona K. Bartholomew, PhD4 and Sally W. Vernon, PhD5, (1)University of Michigan, Ann Arbor VA Health System, Ann Arbor, MI, (2)Washington University, St. Louis, MO, (3)Kelsey-Seybold Clinic, Houston, TX, (4)University of Texas School of Public Health, Houston, TX, (5)University of Texas, School of Public Health, Houston, TX
DETERMINANTS OF THE INTENTION OF PREGNANT WOMEN AND THEIR PHYSICIANS TO SHARED DECISIONS REGARDING PRENATAL SCREENING OF DOWN SYNDROME: AN APPLICATION OF THE THEORY OF PLANNED BEHAVIOUR
France Légaré, MD, PhD1, Francois Rousseau, MD2, Sylvie St-Jacques, PhD2, Marc Charland, PhD2, Pierre Fremont, MD, PhD2, Denis D'Amours, MD2 and Suzie Gagnon, BA2, (1)CHUQ Research Center-Hôpital St-François d'Assise, Quebec, QC, Canada, (2)Universite Laval, Quebec, QC, Canada
PATIENTS' PREFERENCES FOR TREATMENT OF HEPATITIS C
Liana Fraenkel, MD, MPH1, Diane Chodkowski, RN2, Carol Eggers, APRN2, Joseph Lim, MD2 and Guadalupe Garcia-Tsao, MD3, (1)Yale University, New Haven, CT, (2)VA CT Healthcare System, Yale University, New Haven, CT, (3)Yale University, VA CT Healthcare System, New Haven, CT
HOW RISK-BLIND ARE CLINICAL DECISIONS ABOUT OSTEOPORORSIS THERAPY BASED ON BONE DENSITY?
Laurie J. Pencille, B.A., C.R.S.C., Stephanie Majka, Sara Heim, Carolyn M. Valone Bell, Lilisbeth Perestelo-Perez, PhD, Rebecca J. Mullan, MSc, Brian Swiglo, M.D., Nilay D. Shah, PhD and Victor M. Montori, MD, MSc, Mayo Clinic, Rochester, MN
DO ICON ARRAYS HELP TO REDUCE BASE-RATE NEGLECT?
Rocio Garcia-Retamero, PhD1, Mirta Galesic, PhD2 and Gerd Gigerenzer, PhD2, (1)Facultad de Psicología, Universidad de Granada, Granada, Spain, (2)Max Planck Institute for Human Development, Berlin, Germany
PERCEIVED RISK OF CANCER RECURRENCE, TRUST AND QUALITY OF LIFE AMONG CANCER SURVIVORS
Erika A. Waters, PhD, MPH1, Neeraj Arora, PhD1, William M.P. Klein, PhD2 and Paul K. J. Han, MD, MA, MPH1, (1)National Cancer Institute, Bethesda, MD, (2)University of Pittsburgh, Pittsburgh, PA
ARE BREAST CANCER PATIENTS GETTING THE "GIST" IN COMMUNICATION ABOUT TREATMENT RISKS?
David W. Hutton, MS1, Dan H. Moore, PhD2, Ross Shachter, PhD1 and Jeffrey K. Belkora, PhD2, (1)Stanford University, Stanford, CA, (2)University of California, San Francisco, San Francisco, CA
THE IMPORTANCE OF PATIENTS' PERCEIVED INVOLVEMENT IN DECISION MAKING DURING THE PRE-ANAESTHESIA ASSESSMENT
Heidi U. Linnen, MD, PhD, Isabel Schwerdt, Edith Weiss-Gerlach, Andreas Ramme and Claudia D. Spies, MD, PhD, Charité University Medicine Berlin, Berlin, Germany
COST-EFFECTIVENESS ANALYSIS OF ROUTINE SCREENING FOR HEPATITIS B PRIOR TO CHEMOTHERAPY FOR NON-HODGKIN'S LYMPHOMA
Walter G. Park, MD1, Maureen Morgan, MD, MPH2 and Ahmad Kamal, MD, MSc2, (1)Stanford University, Stanford, CA, (2)Santa Clara Valley Medical Center, Santa Clara, CA
THE EFFECT OF POSSIBLE WHEEZING ADVERSE EVENTS ON THE COST-EFFECTIVENESS OF NASAL INFLUENZA VACCINE IN CHILDREN
Lisa A. Prosser, PhD1, Virginia Hinrichsen, MS, MPH2 and Tracy A. Lieu2, (1)Henry Ford Health System, Detroit, MI, (2)Harvard Pilgrim Health Care and Harvard Medical School, Boston, MA
![[ Visit Client Website ]](images/banner.gif)